That tidbit came from UnitedHealth Group's year-end earnings report that showed use of medical services were up, prompting health insurer stocks to dip on Friday.
The insurer's report suggests that the RSV shots, which were approved for adults 60 and older as well as infants, are helping to drive at least some demand for care.
Heightened COVID activity and an ongoing shift in seniors' elevated use of services, such as outpatient care and orthopedic surgeries, also increased costs, CEO Andrew Witty told investors.
[
add
]
[
|
|
...
]